Bayer, TAP “Average Sales Price” To Replace Medicare AWP In House Bill
Executive Summary
The House Energy & Commerce Committee is drafting legislation to use the "average sales price" formula negotiated by Bayer and TAP in recent settlements of False Claims Act cases as a replacement for the "average wholesale price" payment methodology for Medicare
You may also be interested in...
AWP Class Action Proceeds; Congress’ Inaction Is No Defense, Judge Rules
Pharmaceutical manufacturers cannot use the lack of Congressional action on AWP reform as a defense in class action suits filed over the issue, Boston federal court Judge Patti Saris ruled
AWP Class Action Proceeds; Congress’ Inaction Is No Defense, Judge Rules
Pharmaceutical manufacturers cannot use the lack of Congressional action on AWP reform as a defense in class action suits filed over the issue, Boston federal court Judge Patti Saris ruled
Oral Cancer Drug Coverage Bill May Move In Combo With AWP Reform
Sen. John Rockefeller (D-W.Va.) would like to tie a bill providing for Medicare coverage of oral cancer therapies with reform of the AWP reimbursement system for drugs already covered by Medicare